Jeffrey Epstein, Hedge Fund Mogul, Highlights Alzheimer's as the 3rd Leading Cause of Death

Headshot of Jeffrey Epstein

The Jeffrey Epstein VI Foundation backs a critical study that advances Alzheimer's as the 3rd leading cause of death in the United States.

The cause of Alzheimer’s is still unknown, and a cure for Alzheimer’s must be prioritized.
— Jeffrey Epstein
NEW YORK, NY, USA, March 24, 2014 / -- The science philanthropist, Jeffrey Epstein, founder of the Program for Evolutionary Dynamics at Harvard University, and prominent supporter of the Alzheimer’s Association, has backed and highlighted a critical study showing that Alzheimer’s is no longer the 6th leading cause of death in the United States, as stated by the Center for Disease Control, but the 3rd.

“The study is critical,” Jeffrey Epstein asserted, whose foundation, the Jeffrey Epstein VI Foundation supports medical research worldwide. “The cause of Alzheimer’s is still unknown, and a cure for Alzheimer’s must be prioritized.”

The study, conducted at Rush University Medical Center in Chicago, and published in the American Academy of Neurology, surveyed 2,566 patients age 65 and older, who were undergoing annual testing for dementia. Results showed that after an average of 8 years, 1,090 patients died. The average time from diagnosis to death was about 4 years and post mortem, Alzheimer’s disease was identified in about 90% of those clinically diagnosed. The death rate was more than four times higher after a diagnosis of Alzheimer’s in people age 75 to 84 and three times higher in people age 85 and older.

Huge strides have been made in understanding the disease. For example, in a ground breaking study published in Nature and financed by the Alzheimer's Association and the Jeffrey Epstein VI Foundation amongst others, scientists from Rochester University and the University of Southern California showed how the gene ApoE4 can unleash an excess of the protein cyclophilin A into the cardiovascular system, causing inflammation in atherosclerosis and other conditions. The study also found that ApoE4 makes it more likely for cyclophilin A to accumulate in cells that help maintain the blood-brain barrier, reducing blood to the brain and allowing toxins to infiltrate.

“We are getting closer to understanding exactly how a genetic disposition can disrupt the brain," Jeffrey Epstein remarked.

Jeffrey Epstein is a former board member of the Mind, Brain and Behavior Committee at Harvard and plays an active role at the Institute for Advanced Studies at Princeton.

Press release courtesy of Online PR Media:

Jeffrey Epstein
Jeffrey Epstein VI Foundation
(917) 573-7604
email us here